ETRA

Electra Therapeutics, Inc.

Insider activity for last month from 08/22 to 09/22. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Latest filingSep 21, 2026Most recent Form 4
Total buying$00 buys
Total selling$00 sells
Net open-market+$04 insiders
Open-market mix
Buy vs sell distribution by transaction count
0 transactions

Insider activity report

Monthly open-market purchase and sale counts
Buys Sells
530-3-5transactionsAugSep

Transaction codes

By Form 4 transaction code in selected period
8transactions
  • C · Code C · dominant8 · 100%

Activity by reported role

A joint filing can contribute to multiple roles
10transactions
  • Chief executive officer · dominant2 · 20%
  • CSO2 · 20%
  • CTO2 · 20%
  • Director2 · 20%
  • PRES2 · 20%

Distinct insiders active

Reporting-owner CIKs by month · peak Sep 2026 (4)
Aug 2026Sep 2026
4distinct insiders in 2 months

Reported Holdings After

Separated by insider, security, and ownership type
Dong Quehuong (Kathy)Series A Convertible Preferred Stock · Direct
00Sep 21, 2026 · 0 shares owned afterSep 21, 2026Sep 21, 2026
0Sep 21, 2026
Dong Quehuong (Kathy)Common Stock · Direct
455.5k455.5kSep 21, 2026 · 455,484 shares owned afterSep 21, 2026Sep 21, 2026
455,484Sep 21, 2026
Parry GrahamSeries A Convertible Preferred Stock · Direct
00Sep 21, 2026 · 0 shares owned afterSep 21, 2026Sep 21, 2026
0Sep 21, 2026
Parry GrahamCommon Stock · Direct
85.5k85.5kSep 21, 2026 · 85,504 shares owned afterSep 21, 2026Sep 21, 2026
85,504Sep 21, 2026
Stagliano NancySeries A Convertible Preferred Stock · Direct
00Sep 21, 2026 · 0 shares owned afterSep 21, 2026Sep 21, 2026
0Sep 21, 2026
Stagliano NancyCommon Stock · Direct
255.6k255.6kSep 21, 2026 · 255,635 shares owned afterSep 21, 2026Sep 21, 2026
255,635Sep 21, 2026
Koe Gary S.Series A Convertible Preferred Stock · Direct
00Sep 21, 2026 · 0 shares owned afterSep 21, 2026Sep 21, 2026
0Sep 21, 2026
Koe Gary S.Common Stock · Direct
63.7k63.7kSep 21, 2026 · 63,656 shares owned afterSep 21, 2026Sep 21, 2026
63,656Sep 21, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells red
1 active days
Aug 22Sep 22
LessMore
Top insiders
By absolute net value across the selected period
4 insiders
  • KS
    Koe Gary S.CTO · rank 1 · 0 buys · 0 sells
    +$0last 09/21/undefined
  • SN
    Stagliano NancyDIR · rank 2 · 0 buys · 0 sells
    +$0last 09/21/undefined
  • PG
    Parry GrahamCSO · rank 3 · 0 buys · 0 sells
    +$0last 09/21/undefined
  • D(
    Dong Quehuong (Kathy)PRES, CEO · rank 4 · 0 buys · 0 sells
    +$0last 09/21/undefined
Recent filing activity
Most recent 8 transactions · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale-
10b5-1 detected0
Amended rows0

Filing-only signals

Deterministic matches in the selected period

No filing-only signal badges matched this period.

ETRA transaction history

Filters apply within this company and selected period by default
Reset

Latest insider transactions

Form 4 filings from last month. Click any column to sort; click it again to flip the order.

Newest company filings
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#227065ETRAKoe Gary S.
CTO
unknown63.6kC09/2109/21
#227064ETRAKoe Gary S.
CTO
unknown63.6kC09/2109/21
#227058ETRAStagliano Nancy
DIR
unknown255kC09/2109/21
#227057ETRAStagliano Nancy
DIR
unknown255kC09/2109/21
#227055ETRAParry Graham
CSO
unknown85.5kC09/2109/21
#227054ETRAParry Graham
CSO
unknown85.5kC09/2109/21
#227050ETRADong Quehuong (Kathy)
PRESCEO
unknown455kC09/2109/21
#227049ETRADong Quehuong (Kathy)
PRESCEO
unknown455kC09/2109/21

Electra Therapeutics, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Electra Therapeutics, Inc.?

Koe Gary S., Stagliano Nancy, Parry Graham, Dong Quehuong (Kathy).

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

No code-P purchases or code-S sales were reported in the selected period.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.